Home > Insider Trading > Filing (0001209191-19-059244)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
820081	Cambrex Corp	CBM	Pharmaceutical Preparations (2834)	222476135

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1632229	Samantha Hanley	One Meadowlands Plaza East Rutherford NJ 07073	Svp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-12-04	2,500	$17.81	3,631	No	4	M	Direct
Common Stock	Acquisiton	2019-12-04	3,750	$22.50	7,381	No	4	M	Direct
Common Stock	Acquisiton	2019-12-04	12,500	$41.36	19,881	No	4	M	Direct
Common Stock	Acquisiton	2019-12-04	18,750	$40.65	38,631	No	4	M	Direct
Common Stock	Acquisiton	2019-12-04	20,000	$45.64	58,631	No	4	M	Direct
Common Stock	Acquisiton	2019-12-04	20,000	$53.61	78,631	No	4	M	Direct
Common Stock	Disposition	2019-12-04	78,631	$60.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2019-12-04	2,500	$0.00	2,500	$17.81
Common Stock	Stock Option (right to buy)	Acquisiton	2019-12-04	3,750	$0.00	3,750	$22.50
Common Stock	Stock Option (right to buy)	Acquisiton	2019-12-04	12,500	$0.00	12,500	$41.36
Common Stock	Stock Option (right to buy)	Acquisiton	2019-12-04	18,750	$0.00	18,750	$40.65
Common Stock	Stock Option (right to buy)	Acquisiton	2019-12-04	20,000	$0.00	20,000	$45.64
Common Stock	Stock Option (right to buy)	Acquisiton	2019-12-04	20,000	$0.00	20,000	$53.61

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct

Footnotes

Disposed of for $60.00 per share pursuant to the terms of that certain Agreement and Plan of Merger dated as of August 7, 2019, by and among Catalog Intermediate Inc. ("Parent"), Catalog Merger Sub ("Merger Sub"), each entities controlled by investment funds advised by Permira Advisors LLC, and the Company (the "Merger Agreement"). All terms capitalized but not defined shall have the respective meanings given to them in the Merger Agreement.
Each option to purchase shares of Company Common Stock (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive an amount in cash, without interest thereon, equal to the product of $60.00 (less the exercise price per share attributable to such Company Option), multiplied by the total number of shares of Company Common Stock issuable upon exercise in full of such Company Option, provided that if the exercise price per share of any such Company Option was equal to or greater than $60.00, such Company Option was cancelled for no consideration. The Company Options reported herein were canceled in the merger in exchange for a cash payment of $60.00 per share subject to such Company Option.